New Guidelines for Care of Advanced Prostate Cancer Released

New Guidelines for Care of Advanced Prostate Cancer Released
The American Urological Association (AUA), American Society for Radiation Oncology (ASTRO), and Society of Urologic Oncology (SUO) have released new guidelines for the diagnosis and treatment of advanced prostate cancer, the associations announced. These guidelines were developed by a panel of experts that a patient advocate. In addition to their own expertise and experience, panel members assessed data from 264 prostate cancer studies in developing these recommendations for clinical practice. "For the past several years, the prostate cancer landscape has been rapidly evolving due to changes in PSA (prostate-specific antigen) screening standards, as well as the approval of new classes of treatment options for use in various prostate cancer disease states," William Lowrance, MD, MPH, chair of the guideline panel and a professor at the University of Utah, said in a press release. "This guideline is comprised of clinical recommendations based on this new evidence and aims to further support the medical community and patients as they navigate through the various stages of this disease," Lowrance added. In total, the panel released 38 individual guidelines, grouped into six overarching themes. These are early evaluation and counseling, recurrence without metastatic disease (local treatment exhausted), metastatic hormone-sensitive cancer, non-metastatic castration-resistant disease, metastatic castration-resistant cancer, and bone health. The first three guidelines concern early evaluation and counseling for people diagnosed with prostate cancer. They stress the importance of interdisciplinary care, and the management of pain and other symptoms for patients, noting they should be included in decisions about their care. The guidelines also note the importance of
Subscribe or to access all post and page content.